LLY
Eli Lilly and Company
Eli Lilly and Company historical holders
total: 12
Causeway Capital Management Eli Lilly and Company transactions over time
- Total transactions:
- 19
- New positions:
- 1
- Sold out:
- 1
- Added:
- 8
- Reduced:
- 9
- Held since:
- 2014 Q3
- Held for:
- 18 quarters
- Latest activity:
- 2019 Q1
Sarah Ketterer has been an institutional investor in Eli Lilly and Company (LLY) since 2014 Q3. According to 2026 Q1 report, Sarah Ketterer doesn't hold any shares. The fund/company first acquired LLY in 2014 Q3, initially purchasing about 1.34M shares. Since the initial investment, Causeway Capital Management has made 18 more transactions in this position.
When did Sarah Ketterer exit their LLY position?
Sarah Ketterer no longer holds Eli Lilly and Company (LLY). They sold off their entire position in 2019 Q1, closing out an investment that began in 2014 Q3.
When did Sarah Ketterer first invest in LLY?
Sarah Ketterer first invested in Eli Lilly and Company (LLY) in 2014 Q3 at the reported quarter-end price of $70.75 per share, acquiring 1,338,392 shares in their initial purchase.
What is Sarah Ketterer's average cost basis for LLY?
Based on historical transaction data, Sarah Ketterer's estimated cost basis for Eli Lilly and Company (LLY) is approximately $80.27 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $80.27
- Weighted AVG sell price:
- $100.31
LLY transactions history by Causeway Capital Management
19 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2019 Q1
|
0.00%
|
$111.11
|
-100% (-81)
|
|||
|
2018 Q4
|
0.00%
|
$111.11
|
-99.99% (-1,107,491)
|
|||
|
2018 Q3
|
1.19%
|
$107.31
|
-59.54% (-1,629,986)
|
|||
|
2018 Q2
|
2.36%
|
$85.33
|
-26.13% (-968,402)
|
|||
|
2018 Q1
|
3.07%
|
$77.37
|
+28.68% (+825,928)
|
|||
|
2017 Q4
|
2.58%
|
$84.46
|
-4.25% (-127,928)
|
|||
|
2017 Q3
|
2.89%
|
$85.54
|
-7.99% (-261,293)
|
|||
|
2017 Q2
|
3.33%
|
$82.30
|
+35.88% (+863,319)
|
|||
|
2017 Q1
|
3.14%
|
$96.28
|
-22.42% (-695,231)
|
|||
|
2016 Q4
|
4.70%
|
$86.56
|
+34.05% (+787,752)
|
|||
|
2016 Q3
|
3.84%
|
$90.35
|
+3.60% (+80,488)
|
|||
|
2016 Q2
|
4.29%
|
$90.25
|
+37.53% (+609,341)
|
|||
|
2016 Q1
|
3.13%
|
$83.83
|
+30.79% (+382,237)
|
|||
|
2015 Q4
|
2.66%
|
$101.34
|
-17.64% (-265,830)
|
|||
|
2015 Q3
|
3.13%
|
$103.40
|
+2.95% (+43,199)
|
|||
|
2015 Q2
|
3.58%
|
$97.73
|
-6.53% (-102,308)
|
|||
|
2015 Q1
|
4.01%
|
$98.07
|
-5.41% (-89,626)
|
|||
|
2014 Q4
|
3.72%
|
$77.67
|
+23.72% (+317,520)
|
|||
|
2014 Q3
|
3.28%
|
$70.75
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.